Lymphoma, T-Cell, Cutaneous

specific

The reemergence of primary cutaneous T-cell non-Hodgkin lymphoma after a period of remission.

22

Centers

10

Active Trials

Cancer Funding

Top Centers for Lymphoma, T-Cell, Cutaneous(22)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
64.5
2
NCI Comprehensive
Active Research Program
64.5
3
NCI Comprehensive
Active Research Program
64.5
4
NCI Comprehensive
Active Research Program
64.5
5
NCI Comprehensive
Active Research Program
64.5
6
NCI Comprehensive
Active Research Program
64.5
7
Active Research Program
64.5
8
Active Research Program
64.5
9
Active Research Program
64.5
10
Active Research Program
64.5
11
NCI Comprehensive
42.0
12
NCI Comprehensive
42.0
13
NCI Comprehensive
42.0
14
NCI Comprehensive
42.0
15
NCI Comprehensive
42.0
16
NCI Comprehensive
42.0
1742.0
1842.0
1942.0
2042.0
21
NCI Comprehensive
42.0
2242.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →